John Wiley & Sons Enzyme Technologies Cover Enzyme Technologies in Drug Discovery highlights how, what, and where enzymes have become critical i.. Product #: 978-0-470-28624-1 Regular price: $151.40 $151.40 Auf Lager

Enzyme Technologies

Metagenomics, Evolution, Biocatalysis and Biosynthesis

McCarthy, James R. / Yang, Hsiu-Chiung / Yeh, Wu-Kuang

Chemical Biology of Enzymes for Biotechnology and Pharmaceutical Applications

Cover

1. Auflage Oktober 2010
388 Seiten, Hardcover
Wiley & Sons Ltd

ISBN: 978-0-470-28624-1
John Wiley & Sons

Probekapitel

Kurzbeschreibung

Enzyme Technologies in Drug Discovery highlights how, what, and where enzymes have become critical in pharmaceutical and biotechnology research. This book provides in-depth reviews of recent developments in biosynthesis, biocatalysis, and the chemical biology of enzymes. This text discusses enzymatic assays, including emerging assay technologies for key enzyme classes in pharmaceutical research. In addition to new developments in proteomics, this book includes two emerging technologies in life sciences, metabolomics and preclinomics. This volume reviews important progress on the chemical biology of enzymes in the post-genomic era.

Jetzt kaufen

Preis: 162,00 €

Preis inkl. MwSt, zzgl. Versand

Weitere Versionen

mobipdf

Enzyme Technologies in Drug Discovery highlights how, what, and where enzymes have become critical in pharmaceutical and biotechnology research. This book provides in-depth reviews of recent developments in biosynthesis, biocatalysis, and the chemical biology of enzymes. This text discusses enzymatic assays, including emerging assay technologies for key enzyme classes in pharmaceutical research. In addition to new developments in proteomics, this book includes two emerging technologies in life sciences, metabolomics and preclinomics. This volume reviews important progress on the chemical biology of enzymes in the post-genomic era.

Wu-Kuang Yeh, PhD, is Executive Consultant and was director of research and principal investigator at PreClinOmics, Inc., from 2004-2010. He was a principal research scientist at Eli Lilly and Company from 1982-2004. He is the author or coauthor of over 115 abstracts and publications, coeditor of one book, and the holder of six U.S. patents.

Hsiu-Chiung Yang, PhD, is a Research Advisor at Eli Lilly and Company.? She was a principal research scientist at Eli Lilly and Company from 1998-2007 and is the author or coauthor of over forty abstracts and publications, as well as co-inventor of one patent.?

James R. Mccarthy, PhD, is the author, coauthor, or coeditor of over 125 scientific publications and holder of over forty U.S. patents. He is on the editorial advisory board of the Journal of Medicinal Chemistry and is a past chair of the division of Medicinal Chemistry of the American Chemical Society. He also serves as a Senior Scientific Advisor for the Huntington Disease Research Foundation.